GrOwnValve GmbH

GrOwnValve Achieves Primary Safety Endpoint in First-in-Human Heart Valve Study

All five patients complete six-month follow-up without predefined prosthesis-related safety events BERLIN, Oct. 26, 2026 — GrOwnValve GmbH, a…